Literature DB >> 11526152

Novel method for detection, typing, and quantification of human papillomaviruses in clinical samples.

K W Hart1, O M Williams, N Thelwell, A N Fiander, T Brown, L K Borysiewicz, C M Gelder.   

Abstract

We report the development of a novel detection and typing methodology for human papillomaviruses (HPV) based on real-time PCR with the self-probing fluorescent primers known as Scorpions. This technique is quick, simple, specific, sensitive, and capable of estimating viral load per cell. We report the results of over 100 typing reactions performed on cell lines, biopsies, and cervical cytobrush samples which, when compared to the current reference HPV detection and typing technique, present a kappa value of 0.89. We further report preliminary data suggesting a relationship between viral load per cell and grade of cervical disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11526152      PMCID: PMC88320          DOI: 10.1128/JCM.39.9.3204-3212.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  28 in total

1.  Human papillomavirus testing for primary cervical cancer screening.

Authors:  J Cuzick
Journal:  JAMA       Date:  2000-01-05       Impact factor: 56.272

2.  Detection of PCR products using self-probing amplicons and fluorescence.

Authors:  D Whitcombe; J Theaker; S P Guy; T Brown; S Little
Journal:  Nat Biotechnol       Date:  1999-08       Impact factor: 54.908

3.  Improved amplification of genital human papillomaviruses.

Authors:  P E Gravitt; C L Peyton; T Q Alessi; C M Wheeler; F Coutlée; A Hildesheim; M H Schiffman; D R Scott; R J Apple
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

4.  HPV typing and testing in gynaecological pathology: has the time come?

Authors:  C J Meijer; T J Helmerhorst; L Rozendaal; J C van der Linden; F J Voorhorst; J M Walboomers
Journal:  Histopathology       Date:  1998-07       Impact factor: 5.087

5.  Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective.

Authors:  T Yamada; M M Manos; J Peto; C E Greer; N Munoz; F X Bosch; C M Wheeler
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

6.  Screening for cervical cancer.

Authors:  J Cuzick; C J Meijer; J M Walboomers
Journal:  Lancet       Date:  1998-05-09       Impact factor: 79.321

7.  Evaluation of a human papillomavirus assay in cervical screening in Zimbabwe.

Authors:  S D Womack; Z M Chirenje; P D Blumenthal; L Gaffikin; J A McGrath; T Chipato; E Ngwalle; K V Shah
Journal:  BJOG       Date:  2000-01       Impact factor: 6.531

8.  Estimates of the worldwide frequency of sixteen major cancers in 1980.

Authors:  D M Parkin; E Läärä; C S Muir
Journal:  Int J Cancer       Date:  1988-02-15       Impact factor: 7.396

9.  Cervical lesions are associated with human papillomavirus type 16 intratypic variants that have high transcriptional activity and increased usage of common mammalian codons.

Authors:  J M Bible; C Mant; J M Best; B Kell; W G Starkey; K Shanti Raju; P Seed; C Biswas; P Muir; J E Banatvala; J Cason
Journal:  J Gen Virol       Date:  2000-06       Impact factor: 3.891

10.  Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type.

Authors:  D C Swan; R A Tucker; G Tortolero-Luna; M F Mitchell; L Wideroff; E R Unger; R A Nisenbaum; W C Reeves; J P Icenogle
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

View more
  7 in total

1.  Quantitative screening of single copies of human papilloma viral DNA without amplification.

Authors:  Jiangwei Li; Ji-Young Lee; Edward S Yeung
Journal:  Anal Chem       Date:  2006-09-15       Impact factor: 6.986

2.  Development of a microtiter plate hybridization-based PCR-enzyme-linked immunosorbent assay for identification of clinically relevant human group A rotavirus G and P genotypes.

Authors:  Norma Santos; Shinjiro Honma; Maria do Carmo S T Timenetsky; Alexandre C Linhares; Hiroshi Ushijima; George E Armah; Jon R Gentsch; Yasutaka Hoshino
Journal:  J Clin Microbiol       Date:  2007-12-05       Impact factor: 5.948

3.  Real-time PCR-based system for simultaneous quantification of human papillomavirus types associated with high risk of cervical cancer.

Authors:  Martin Moberg; Inger Gustavsson; Ulf Gyllensten
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

4.  Development and clinical evaluation of a highly sensitive DNA microarray for detection and genotyping of human papillomaviruses.

Authors:  Tae Jeong Oh; Chang Jin Kim; Suk Kyung Woo; Tae Seung Kim; Dong Jun Jeong; Myung Soon Kim; Sunwoo Lee; Hyun Sill Cho; Sungwhan An
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

5.  Quantitation of cytomegalovirus (hCMV) DNA and beta-actin DNA by duplex real-time fluorescence PCR in solid organ (liver) transplant recipients.

Authors:  Joachim Hänfler; Karl Anton Kreuzer; Katja Laurisch; Nada Rayes; Peter Neuhaus; Christian Andreas Schmidt; Helmut Oettle
Journal:  Med Microbiol Immunol       Date:  2003-01-30       Impact factor: 3.402

6.  The Effect of Indian Fig Fruit Extract on Human Papilloma Virus containing Cervical Cancer Cells (HeLa) by Decreasing the HPV18 L1 Gene Load.

Authors:  V M Berlin Grace; Lydia B; D David Wilson
Journal:  Asian Pac J Cancer Prev       Date:  2021-03-01

7.  HPV infection, risk factors and viral load among Mexican male college students.

Authors:  Carmina Vera-Uehara; Miguel Angel Sánchez-Alemán; Felipe Javier Uribe-Salas; José Ramos-Castañeda; Ma Leónidez Olamendi-Portugal; Carlos Jesús Conde-Glez
Journal:  Braz J Infect Dis       Date:  2013-09-19       Impact factor: 3.257

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.